Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia
Open Access
- 2 October 2009
- journal article
- Published by Wiley in Genes, Brain and Behavior
- Vol. 8 (7) , 661-675
Abstract
N‐methyl‐D‐aspartate receptors (NMDARs) play a pivotal role in excitatory neurotransmission, synaptic plasticity and brain development. Clinical and experimental evidence suggests a dysregulation of NMDAR function and glutamatergic pathways in the pathophysiology of schizophrenia. We evaluated electrophysiological and behavioral properties of NMDAR deficiency utilizing mice that express only 5–10% of the normal level of NMDAR NR1 subunit. Auditory and visual event related potentials yielded significantly increased amplitudes for the P20 and N40 components in NMDAR deficient (NR1neo−/−) mice suggesting decreased inhibitory tone. Compared to wild types, NR1neo−/− mice spent less time in social interactions and showed reduced nest building. NR1neo−/− mice displayed a preference for open arms of a zero maze and central zone of an open field, possibly reflecting decreased anxiety‐related behavioral inhibition. However, locomotor activity did not differ between groups in either home cage environment or during behavioral testing. NR1neo−/− mice displayed hyperactivity only when placed in a large unfamiliar environment, suggesting that neither increased anxiety nor non‐specific motor activation accounts for differential behavioral patterns. Data suggest that NMDAR NR1 deficiency causes disinhibition in sensory processing as well as reduced behavioral inhibition and impaired social interactions. The behavioral signature in NR1neo−/− mice supports the impact of impaired NMDAR function in a mouse model with possible relevance to negative symptoms in schizophrenia.Keywords
This publication has 35 references indexed in Scilit:
- Seizure responses and induction of Fos by the NMDA Agonist (tetrazol-5-yl)glycine in a genetic model of NMDA receptor hypofunctionBrain Research, 2008
- Cognition-enhancing and anxiolytic effects of memantineNeuropharmacology, 2008
- Early Auditory Sensory Processing Deficits in Mouse Mutants with Reduced NMDA Receptor FunctionNeuropsychopharmacology, 2007
- Social approach–avoidance behavior of inbred mouse strains towards DBA/2 miceBrain Research, 2004
- Modulating sensory gating in healthy volunteersBiological Psychiatry, 2002
- Social and neural determinants of aggressive behavior: pharmacotherapeutic targets at serotonin, dopamine and ?-aminobutyric acid systemsPsychopharmacology, 2002
- Severe Impairment of NMDA Receptor Function in Mice Carrying Targeted Point Mutations in the Glycine Binding Site Results in Drug-Resistant Nonhabituating HyperactivityJournal of Neuroscience, 2002
- Effects of Ketamine in Normal and Schizophrenic VolunteersNeuropsychopharmacology, 2001
- The Emerging Role of Glutamate in the Pathophysiology and Treatment of SchizophreniaAmerican Journal of Psychiatry, 2001
- Catching Up on SchizophreniaNeuron, 2000